Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

The potential for elimination of racial-ethnic disparities in HIV treatment initiation in the Medicaid population among 14 southern states.

Zhang S, McGoy SL, Dawes D, Fransua M, Rust G, Satcher D.

PLoS One. 2014 Apr 25;9(4):e96148. doi: 10.1371/journal.pone.0096148.

2.

Racial/ethnic disparities in antiretroviral treatment among HIV-infected pregnant Medicaid enrollees, 2005-2007.

Zhang S, Senteio C, Felizzola J, Rust G.

Am J Public Health. 2013 Dec;103(12):e46-53. doi: 10.2105/AJPH.2013.301328.

3.

Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.

Beer L, Mattson CL, Bradley H, Skarbinski J; Medical Monitoring Project..

Medicine (Baltimore). 2016 Mar;95(13):e3171. doi: 10.1097/MD.0000000000003171.

4.

Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.

Yee LM, Liu LY, Sakowicz A, Bolden JR, Miller ES.

Am J Obstet Gynecol. 2016 Mar;214(3):374.e1-6. doi: 10.1016/j.ajog.2015.12.054.

PMID:
26829989
5.

The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?

Shone LP, Dick AW, Brach C, Kimminau KS, LaClair BJ, Shenkman EA, Col JF, Schaffer VA, Mulvihill F, Szilagyi PG, Klein JD, VanLandeghem K, Bronstein J.

Pediatrics. 2003 Dec;112(6 Pt 2):e521.

PMID:
14654674
6.

Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.

Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF.

Public Health Rep. 2002 May-Jun;117(3):252-62; discussion 231-2.

7.

Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status.

Cook BL, Alegría M.

Psychiatr Serv. 2011 Nov;62(11):1273-81. doi: 10.1176/appi.ps.62.11.1273.

8.

Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.

Lillie-Blanton M, Stone VE, Snow Jones A, Levi J, Golub ET, Cohen MH, Hessol NA, Wilson TE.

Am J Public Health. 2010 Aug;100(8):1493-9. doi: 10.2105/AJPH.2008.158949.

9.

Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.

McFall AM, Dowdy DW, Zelaya CE, Murphy K, Wilson TE, Young MA, Gandhi M, Cohen MH, Golub ET, Althoff KN; Women's Interagency HIV Study..

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):289-98. doi: 10.1097/QAI.0b013e3182a095e9.

10.

Racial/Ethnic Disparities Associated With Initial Hemodialysis Access.

Zarkowsky DS, Arhuidese IJ, Hicks CW, Canner JK, Qazi U, Obeid T, Schneider E, Abularrage CJ, Freischlag JA, Malas MB.

JAMA Surg. 2015 Jun;150(6):529-36. doi: 10.1001/jamasurg.2015.0287.

PMID:
25923973
11.

Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies.

Morin SF, Sengupta S, Cozen M, Richards TA, Shriver MD, Palacio H, Kahn JG.

Public Health Rep. 2002 May-Jun;117(3):263-72; discussion 231-2.

12.

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, Hellinger J, Keiser P, Rubin HR, Crane L, Hellinger FJ, Mathews WC; HIV Research Network..

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103.

PMID:
15608532
13.

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.

Aparicio HJ, Carr BG, Kasner SE, Kallan MJ, Albright KC, Kleindorfer DO, Mullen MT.

J Am Heart Assoc. 2015 Oct 14;4(10):e001877. doi: 10.1161/JAHA.115.001877.

14.

Racial and ethnic disparities in postpartum depression care among low-income women.

Kozhimannil KB, Trinacty CM, Busch AB, Huskamp HA, Adams AS.

Psychiatr Serv. 2011 Jun;62(6):619-25. doi: 10.1176/appi.ps.62.6.619.

15.

Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, Gray KM, Cohen SM, Mermin J, Skarbinski J.

JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.

PMID:
23780395
16.

Can routine offering of influenza vaccination in office-based settings reduce racial and ethnic disparities in adult influenza vaccination?

Maurer J, Harris KM, Uscher-Pines L.

J Gen Intern Med. 2014 Dec;29(12):1624-30. doi: 10.1007/s11606-014-2965-z.

17.

Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Cunningham WE, Markson LE, Andersen RM, Crystal SH, Fleishman JA, Golin C, Gifford A, Liu HH, Nakazono TT, Morton S, Bozzette SA, Shapiro MF, Wenger NS.

J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):115-23.

PMID:
11103041
18.

Racial-ethnic disparities in use of antidepressants in private coverage: implications for the Affordable Care Act.

Jung K, Lim D, Shi Y.

Psychiatr Serv. 2014 Sep 1;65(9):1140-6. doi: 10.1176/appi.ps.201300182.

PMID:
24828481
19.

Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998.

King WD, Minor P, Ramirez Kitchen C, Oré LE, Shoptaw S, Victorianne GD, Rust G.

J Epidemiol Community Health. 2008 Sep;62(9):798-803. doi: 10.1136/jech.2005.045567.

20.

Awareness of racial and ethnic health disparities has improved only modestly over a decade.

Benz JK, Espinosa O, Welsh V, Fontes A.

Health Aff (Millwood). 2011 Oct;30(10):1860-7. doi: 10.1377/hlthaff.2010.0702.

Items per page

Supplemental Content

Support Center